Evidence map›Paper›PMID 34577897›Full record

ArticleMedicina (Kaunas, Lithuania)2021

Ruta Mockute, Alvita Vilkeviciute, Vilma Jurate Balciuniene, Reda Zemaitiene, Rasa Liutkeviciene

Open access · goldAbstract read
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. A Case-Control Study of theMedicina (Kaunas, Lithuania) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ruta MockuteDepartment of Ophthalmology, Lithuanian University of Health Sciences, Medical Academy, Eiveniu 2, LT-50009 Kaunas, Lithuania.
Alvita VilkeviciuteNeuroscience Institute, Lithuanian University of Health Sciences, Medical Academy, Eiveniu 2, LT-50009 Kaunas, Lithuania.ORCID 0000-0002-0427-5568
Vilma Jurate BalciunieneDepartment of Ophthalmology, Lithuanian University of Health Sciences, Medical Academy, Eiveniu 2, LT-50009 Kaunas, Lithuania.
Reda ZemaitieneDepartment of Ophthalmology, Lithuanian University of Health Sciences, Medical Academy, Eiveniu 2, LT-50009 Kaunas, Lithuania.
Rasa LiutkevicieneDepartment of Ophthalmology, Lithuanian University of Health Sciences, Medical Academy, Eiveniu 2, LT-50009 Kaunas, Lithuania.
Lithuanian University of Health Sciences · LT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Macular DegenerationVascular Endothelial Growth Factor AATP Binding Cassette Transporter 1BevacizumabCytochrome P450 Family 4HumansPolymorphism, Single NucleotideTomography, Optical CoherenceABCA1 protein, humanATP Binding Cassette Transporter 1BevacizumabCYP4F2 protein, humanCytochrome P450 Family 4Vascular Endothelial Growth Factor Aage-related macular degenerationallelegene polymorphismsretinal diseasesrs1883025rs2108622

Identifiers

PMID34577897
PMCPMC8470098
OpenAlexW3199215338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.